Boston Scientific today shared new findings supporting intravascular ultrasound (IVUS)-guided percutaneous coronary ...

Evident Vascular, a company creating AI-enabled intravascular ultrasound technology, announced its launch today with $35 million in Series A financing. Vensana Capital led the round. The ...

ATLANTA -- The use of intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) in patients with acute coronary syndromes resulted in better outcomes compared with ...

WASHINGTON, DC – A new study found that intravascular ultrasound (IVUS) -guided intervention in patients with chronic total occlusion (CTO) could improve outcomes compared to a conventional ...

Funding to accelerate development of next-generation intravascular ultrasound platform and support FDA clearance for U.S. market launch SAN JOSE, Calif.–(BUSINESS WIRE)–March 25, 2025– Evident ...

Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective for patients with severely calcified coronary artery disease than ...

March 25, 2026Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help ...

Late breaking trial data examining intravascular ultrasound (IVUS) and treatment benefits in cardiac allograft vasculopathy (thickening of arterial walls) were presented yesterday at the 24th Annual ...

Assessing the extent of left main coronary artery (LMCA) disease can be a considerable challenge. Angiography is the diagnostic technique of choice for assessment of coronary artery disease; however, ...

Arterial and deep venous disease are on the rise: more than 21 million people in the U.S. had peripheral arterial disease (PAD) in 2020, a number that’s expected to rise to 24 million by 2030, while ...